Temporal Profiles of Symptom Scores After Palliative Radiotherapy for Bleeding Gastric Cancer With Adjustment for the Palliative Prognostic Index: An Exploratory Analysis of a Multicentre Prospective Observational Study (JROSG 17–3). Issue 12 (December 2022)

• Record Type: Journal Article
• Authors: Kawamoto, T.; Saito, T.; Kosugi, T.; Nakamura, N.; Wada, H.; Tonari, A.; Ogawa, H.; Mitsuhashi, N.; Yamada, K.; Takahashi, T.; Ito, K.; Sekii, S.; Araki, N.; Nozaki, M.; Heianna, J.; Murotani, K.; Hirano, Y.; Satoh, A.; Onoe, T.; Shikama, N.
• Is Part Of: Clinical oncology. Volume 34:Issue 12(2022)
• Page Start: e505
• Page End: e514
• Publication Date: 2022-12
• Subjects: Abdominal pain -- dyspnoea -- palliative care -- quality improvement -- radiation therapy -- stomach neoplasm; Oncology -- Periodicals; Tumors -- Periodicals; Cancer -- Treatment -- Periodicals; Radiotherapy -- Periodicals; Neoplasms -- Periodicals; Cancer -- Radiotherapy; Cancer -- Treatment; Oncology; Medical radiology; Radiotherapy; Tumors; Electronic journals; Periodicals; 616.994
• DOI: 10.1016/j.clon.2022.05.009
• Languages: English
• ISSNs: 0936-6555

Abstract

Abstract: Aims: Although palliative radiotherapy for gastric cancer may improve some symptoms, it may also have a negative impact due to its toxicity. We investigated whether symptoms improved after radiotherapy with adjustment for the Palliative Prognostic Index (PPI) considering that patients with limited survival tend to experience deterioration of symptoms. Materials and methods: This study was an exploratory analysis of the Japanese Radiation Oncology Study Group study (JROSG 17-3). We assessed six symptom scores (nausea, anorexia, fatigue, shortness of breath, pain at the irradiated area and distress) at registration and 2, 4 and 8 weeks thereafter. We tested whether symptoms linearly improved after adjusting for the baseline PPI. Shared parameter models were used to adjust for potential bias in missing data. Results: The present study analysed all 55 patients enrolled in JROSG 17-3. With time from registration as the only explanatory variable in the model, a significant linear decrease was observed in shortness of breath, pain and distress (slopes, −0.26, −0.22 and −0.19, respectively). Given that the interaction terms (i.e. PPI × time) were not significantly associated with symptom scores in any of the six symptoms, only PPI was included as the main effect in the final multivariable models. After adjusting for the PPI, shortness of breath, pain and distress significantly improved (slope, −0.25, −0.19 and −0.17; P < 0.001, 0.002 and 0.047, respectively). An improvement in fatigue and distress was observed only in patients treated with a biologically effective dose ≤14.4 Gy. Conclusion: Shortness of breath, pain and distress improved after radiotherapy. Moreover, a higher PPI was significantly associated with higher symptom scores at all time points, including baseline. In contrast, PPI did not seem to influence the improvement of these symptoms. Regardless of the expected survival, patients receiving radiotherapy for gastric cancer can expect an improvement in shortness of breath, pain and distress over 8 weeks. Multiple-fraction radiotherapy might hamper the improvement in fatigue and distress by its toxicity or treatment burden. Highlights: Patients receiving radiotherapy for gastric cancer can expect improvement of symptoms. Shortness of breath, pain and distress improved after radiotherapy. Palliative Prognostic Index did not seem to influence the improvement of symptoms. Multiple-fraction radiotherapy might hamper the improvement in fatigue and distress.